Lloyd Marcea Bland 4
4 · Poseida Therapeutics, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Lloyd Marcea Bland
Director
Transactions
- Award
Common Stock
2022-06-16+19,650→ 29,650 total - Award
Stock Option (Right to Buy)
2022-06-16+28,500→ 28,500 totalExercise: $2.01Exp: 2032-06-15→ Common Stock (28,500 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
- [F2]The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.